Company Search:
Advanced Search
Sponsored Links
Fulcrum Therapeutics Inc Company Snapshot
Fulcrum Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fulcrum Therapeutics Inc with three other companies in this sector in UNITED STATES : Sol Gel Technologies Ltd (2020 sales of $8.77 million ), Reata Pharmaceuticals Inc ($9.02 million of which 100% was Pharmaceutical), and Ikena Oncology Inc ($9.19 million of which 100% was Biotechnology & Medical Research).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Fulcrum Therapeutics Inc
  Stock Performance Chart for Fulcrum Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 11.25
(Figures in U.S. Dollars)
1 Week -1.7%   13 Weeks -6.3%  
4 Weeks 1.7%   52 Weeks -17.8%  
Fulcrum Therapeutics Inc Key Data:
  Ticker: FULC Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 8,823,000
(Year Ending Jan 2021).
Employees: 73
  Currency: U.S. Dollars Market Cap: 314,342,618
  Fiscal Yr Ends: December Shares Outstanding: 27,941,566
  Share Type: Common Closely Held Shares: 9,737,445
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.